L. Bardin et al., In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1Areceptor-mediated, behaviorally specific analgesia, EUR J PHARM, 421(2), 2001, pp. 109-114
The experiments examined antinociceptive and intrinsic behavioral effects i
nduced by the prototypical 5-HT1A receptor agonist 8-OH-DPAT (8-hydroxy-2-[
di-n-propylamino] tetralin) in rats. 8-OH-DPAT (0.01-2.5 mg/kg, subcutaneou
s (s.c.)) reduced both the paw licking and paw elevation induced by (2.5%)
formalin injection into the plantar surface of the right hindpaw; it also p
roduced forepaw treading. All of these effects were completely blocked by p
retreatment with WAY 100635 (N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}
-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride) (0.16 mg/kg, s.c.
); prazosin (0.63 mg/kg, s.c.) inhibited forepaw treading, but not 8-OH-DPA
T's action on paw elevation and paw licking. Repeated injection of 8-OH-DPA
T (0.63 mg/kg, s.c.) twice daily for 4 days, markedly reduced 8-OH-DPAT's a
bility to produce forepaw treading, but exerted only little and inconsisten
t effects on its paw licking and paw elevation-inhibiting action. The data
indicate that 8-OH-DPAT exerts an analgesic action in the formalin model of
tonic nociceptive pain; this action is mediated by 5-HT1A receptors, and i
s not confounded by the productive sign (i.e., forepaw treading) of the 5-H
T syndrome which 8-OH-DPAT also induces. (C) 2001 Published by Elsevier Sci
ence B.V.